Literature DB >> 28115157

Virion-incorporated alpha-enolase suppresses the early stage of HIV-1 reverse transcription.

Naoki Kishimoto1, Nozomi Iga1, Kengo Yamamoto1, Nobutoki Takamune2, Shogo Misumi3.   

Abstract

Human immunodeficiency virus type-1 (HIV-1) particles contain not only viral-encoded but also host-encoded proteins. Interestingly, several studies showed that host proteins play a critical role in viral infectivity, replication and/or immunoreactivity in the next target cells. Here, we show that alpha-enolase (ENO1) is incorporated into HIV-1 virions and the virion-incorporated ENO1 prevents the early stage of HIV-1 reverse transcription. We found that viral particles contain two isoforms of ENO1 with different isoelectric points by two-dimensional electrophoresis. Suppression of ENO1 expression by RNA interference in the HIV-1 producer cells decreased ENO1 incorporation into virions without altering the packaging of viral structural proteins and viral production but increased viral infectivity. Although the low-level-ENO1-packaging virus maintained comparable levels of reverse transcriptase activity, viral genomic RNA and tRNALys3 packaging to the control virus, its levels of early cDNA products of reverse transcription were higher than those of the control virus. In contrast, the high-level-ENO1-packaging virus, which was produced from ENO1-overexpressing cells, showed decreased infectivity and the levels of early cDNA products. Taken together, these findings reveal a novel function of ENO1 as a negative regulation factor targeting HIV-1 reverse transcription. Copyright Â
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha-enolase; Human immunodeficiency virus type 1; Reverse transcription

Mesh:

Substances:

Year:  2017        PMID: 28115157     DOI: 10.1016/j.bbrc.2017.01.096

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis.

Authors:  Adekunle Alabi; Xiao-Dan Xia; Hong-Mei Gu; Faqi Wang; Shi-Jun Deng; Nana Yang; Ayinuer Adijiang; Donna N Douglas; Norman M Kneteman; Yazhuo Xue; Li Chen; Shucun Qin; Guiqing Wang; Da-Wei Zhang
Journal:  Nat Commun       Date:  2021-03-25       Impact factor: 14.919

2.  Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling.

Authors:  Sara Svensson Akusjärvi; Anoop T Ambikan; Shuba Krishnan; Soham Gupta; Maike Sperk; Ákos Végvári; Flora Mikaeloff; Katie Healy; Jan Vesterbacka; Piotr Nowak; Anders Sönnerborg; Ujjwal Neogi
Journal:  iScience       Date:  2021-12-10

3.  Arginyl-tRNA-protein transferase 1 contributes to governing optimal stability of the human immunodeficiency virus type 1 core.

Authors:  Naoki Kishimoto; Ryosuke Okano; Ayano Akita; Satoshi Miura; Ayaka Irie; Nobutoki Takamune; Shogo Misumi
Journal:  Retrovirology       Date:  2021-09-26       Impact factor: 3.768

4.  SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.

Authors:  Benhong Xu; Yuxuan Lei; Xiaohu Ren; Feng Yin; Weihua Wu; Ying Sun; Xiaohui Wang; Qian Sun; Xifei Yang; Xin Wang; Renli Zhang; Zigang Li; Shisong Fang; Jianjun Liu
Journal:  ACS Omega       Date:  2021-06-24

5.  Alpha-enolase in viral target cells suppresses the human immunodeficiency virus type 1 integration.

Authors:  Naoki Kishimoto; Kengo Yamamoto; Nozomi Iga; Chie Kirihara; Towa Abe; Nobutoki Takamune; Shogo Misumi
Journal:  Retrovirology       Date:  2020-09-11       Impact factor: 4.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.